NCT00010127View on ClinicalTrials.gov

Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer

PHASE1TerminatedINTERVENTIONAL

Enrollment

3

Participants

Timeline

Start Date

November 30, 2000

Study Completion Date

March 31, 2003

Conditions

Prostate Cancer

Interventions

BIOLOGICAL

therapeutic autologous dendritic cells

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER